Risk Factors of Venous Thromboembolism in Sudanese Pregnant Women
By:
References
- Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017; 359: j4452.
- Seligsohn U, Lubetsky A. Medical progress: Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16): 1222–1231.
- Roozbeh N, Banihashemi F, Mehraban M, Abdi F. Potential role of Factor V Leiden mutation in adverse pregnancy outcomes: An updated systematic review. Biomed Res Ther. 2017; 4(12): 1832–1846.
- Cernera G, Di Minno A, Amato F, Elce A, Liguori R, Bruzzese D, et al. Molecular analysis of prothrombotic gene variants in venous thrombosis: A potential role for sex and thrombotic localization. J Clin Med. 2020; 9(4): 1008.
- Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar A, Al Kharusi L, et al. Venous thromboembolism risk and adequacy of prophylaxis in high risk pregnancy in the Arabian Gulf. Curr Vasc Pharmacol. 2016; 14(4): 368–373.
- James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194(5): 1311–1315.
- Ormesher L, Simcox L, Tower C, Greer IA. Management of inherited thrombophilia in pregnancy. Womens Health (Lond). 2016; 12(4): 433–441.
- Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005; 3(5): 949–954.
- Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002; 167(1): 48–54.
- Elzein HO, Saad AA, Yousif AA, Elamin E, Abdalhabib EK, Elzaki SEG. Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia. Curr Res Transl Med. 2020; 68(2): 77–80.
- Hoffbrand AV, Moss PAH, Editors. Platelets, blood coagulation and haemostasis. Hoffbrand's Essential Hematology, 7th ed. Chichester, West Sussex, UK: John Wiley & Sons, Ltd. 2016: 135–144.
- Kujovich JL. Factor v Leiden thrombophilia. Genet Med. 2011; 13(1): 1–16.
- Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom. Blood. 2013; 121(19): 3953–3961.
- Barillari G, Londero AP, Brenner B, Nauffal D, Muñoz-Torrero JFS, Del Molino F, et al.; RIETE Registry. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry. Eur J Intern Med. 2016; 32: 53–59.
- Knight M, UKOSS Antenatal pulmonary embolism: Risk factors, management and outcomes. BJOG. 2008; 115(4): 453–461.
- Gader AA, Haggaz AED, Adam I. Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag. 2009; 5(1): 85–87.
- Babker AM, Ahmed IAM, Ismail M, Hassan FM, Osman AL, Kandakurti PK, et al. Lack of association between Factor V Leiden G1691A, prothrombin G20210A, MTHFC677T mutations, and early recurrent pregnancy loss in a group of Sudanese women. Open Access Maced J Med Sci. [Internet]. 2020; 8(B): 553–557.
- Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study. QJM. 2006; 99(5): 289–298.
- Elgari MM, Ibrahim NA, Muddathir ARM, Eltoom FM, Ibrahim IM. Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sci. 2017; 12(1): 162–166.
- Ahmed NA, Adam I, Elzaki SEG, Awooda HA, Hamdan HZ. Factor V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with pre-eclampsia, a case-control study. BMC Med Genet. 2019; 20(1): 16–20.
- Curigliano G, Mandalà M, Sbanotto A, Colleoni M, Ferretti G, Bucciarelli P, et al. Factor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis. Support Cancer Ther [Internet]. 2006; 3(2): 98–102.
- Monsuez J-J, Bouali H, Serve E, Boissonnas A, Alhenc-Gelas M. Deep venous thrombosis associated with Factor V Leiden, G20210A mutation, and protein S deficiency. Am J Med. 2003; 114(5): 421–422.
- Franchini M. Utility of testing for factor V Leiden. Blood Transfus. 2012; 10(3): 257–259.
- Farajzadeh M, Bargahi N, Poursadegh Zonouzi A, Farajzadeh D, Pouladi N. Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population. Meta Gene [Internet]. 2014; 2: 505–13.
- Jusić-Karić A, Terzić R, Jerkić Z, Avdić A, Podanin M. Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet. 2016; 19(1): 43–49.
DOI: https://doi.org/10.2478/bjmg-2021-0018 | Journal eISSN: 2199-5761
Language: English
Page range: 49 - 54
Published on: Jun 5, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2022 EK Abdalhabib, A Alfeel, EI Ali, IK Ibrahim, AA Mobarki, G Dobie, HA Hamali, M Saboor, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.